Dr. Srivastava received his B.S. from Rice University, M.D. from University of Texas, trained in pediatrics at UCSF, and in pediatric cardiology at Harvard Medical School.
Dr. Srivastava’s laboratory discovered the genetic basis for some cardiac septal and valve defects, revealed complex signaling, transcriptional, and translational networks that regulate progenitor cells to adopt a cardiac cell fate and subsequently fashion a functioning heart. He has leveraged this knowledge to reprogram fibroblasts directly into cardiomyocyte-like cells for regenerative purposes. Dr. Srivastava is a member of the American Academy of Arts and Sciences and of the National Academy of Medicine.
« Go Back